Wednesday, February 22, 2006

Organ Recall

Organ Recall: "The Food and Drug Administration has taken several safety approaches to ensure in an effort to limit the potential for recall of organs used for transplantation. These are suitability of the donor, proper testing, appropriate processing and shipping of materials, along with the monitoring of any adverse events.

TheCenter for Biologics Evaluation and Research (CBER), part of the FDA, has the responsibility to regulate different types of human tissue and cells transplanted during various types of medical procedures. Though somewhat limited, CBER has a role in any organ recall."